3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
3
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Sarcoma
2
Uterine Cervical Neoplasms
1
Skin Neoplasms
1
Neoplasm Metastasis
1
Leiomyosarcoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Cyclophosphamide
5
Fluorouracil
4
pembrolizumab
3
fludarabine
3
Gemcitabine
3
Docetaxel
3
Cisplatin
3
belinostat
2
Quality of Life
2
Psychiatric Rehabilitation
2
Oxaliplatin
2
Observation
2
Leucovorin
2
Irinotecan
2
Filgrastim
2
Erlotinib Hydrochloride
2
Drug Therapy
2
Cetuximab
2
Carboplatin
2
Blood Specimen Collection
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
umbralisib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
toripalimab
1
seribantumab
1
rucaparib
1
resiquimod
1
poly ICLC
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Tissue Banks
×
Sarcoma
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled